In conclusion, our findings demonstrate that despite immunosuppression, pSOTRs are capable of mounting humoral and CD4 T+ cell responses to both the ancestral strain and new variants of concern after receiving the primary series and multiple booster doses of mRNA COVID-19 vaccines. The gene discussed is CD4; the disease is COVID-19.